These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35839620)

  • 1. Spontaneous and induced adaptive immune responses in Alzheimer's disease: new insights into old observations.
    Chen Y; Colonna M
    Curr Opin Immunol; 2022 Aug; 77():102233. PubMed ID: 35839620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of innate and adaptive immunity in Alzheimer's disease.
    Chen X; Holtzman DM
    Immunity; 2022 Dec; 55(12):2236-2254. PubMed ID: 36351425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral adaptive immunity of the triple transgenic mouse model of Alzheimer's disease.
    St-Amour I; Bosoi CR; Paré I; Ignatius Arokia Doss PM; Rangachari M; Hébert SS; Bazin R; Calon F
    J Neuroinflammation; 2019 Jan; 16(1):3. PubMed ID: 30611289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of innate immunity in Alzheimer's disease.
    Ennerfelt HE; Lukens JR
    Immunol Rev; 2020 Sep; 297(1):225-246. PubMed ID: 32588460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Microglia in Alzheimer's Disease: From Molecular Mechanisms to Potential Therapeutic Targets for Small Molecules.
    Althafar ZM
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: tangle formation, amyloid-β, and microglia in Alzheimer's disease.
    Takata K; Kitamura Y
    J Pharmacol Sci; 2012; 118(3):331-7. PubMed ID: 22382659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform.
    Kolaj I; Imindu Liyanage S; Weaver DF
    Neurochem Int; 2018 Nov; 120():99-111. PubMed ID: 30098379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuroimmune axis of Alzheimer's disease.
    Jorfi M; Maaser-Hecker A; Tanzi RE
    Genome Med; 2023 Jan; 15(1):6. PubMed ID: 36703235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits.
    Scholtzova H; Do E; Dhakal S; Sun Y; Liu S; Mehta PD; Wisniewski T
    J Neurosci; 2017 Jan; 37(4):936-959. PubMed ID: 28123027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology.
    Paasila PJ; Davies DS; Kril JJ; Goldsbury C; Sutherland GT
    Brain Pathol; 2019 Nov; 29(6):726-740. PubMed ID: 30803086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles.
    Singh AK; Mishra G; Maurya A; Awasthi R; Kumari K; Thakur A; Rai A; Rai GK; Sharma B; Kulkarni GT; Singh SK
    Curr Alzheimer Res; 2019; 16(13):1216-1229. PubMed ID: 31481003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia in Alzheimer's Disease.
    Süß P; Schlachetzki JCM
    Curr Alzheimer Res; 2020; 17(1):29-43. PubMed ID: 32048973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
    Laurent C; Buée L; Blum D
    Biomed J; 2018 Feb; 41(1):21-33. PubMed ID: 29673549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function.
    Marsh SE; Abud EM; Lakatos A; Karimzadeh A; Yeung ST; Davtyan H; Fote GM; Lau L; Weinger JG; Lane TE; Inlay MA; Poon WW; Blurton-Jones M
    Proc Natl Acad Sci U S A; 2016 Mar; 113(9):E1316-25. PubMed ID: 26884167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invited Review - Understanding cause and effect in Alzheimer's pathophysiology: Implications for clinical trials.
    Boche D; Nicoll JAR
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):623-640. PubMed ID: 32643143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
    Götz J; Schild A; Hoerndli F; Pennanen L
    Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological Signatures of Alzheimer's Disease.
    Sharma P; Sharma A; Fayaz F; Wakode S; Pottoo FH
    Curr Top Med Chem; 2020; 20(9):770-781. PubMed ID: 32108008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation.
    Luan K; Rosales JL; Lee KY
    Ageing Res Rev; 2013 Jan; 12(1):174-81. PubMed ID: 22728532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease.
    Landlinger C; Oberleitner L; Gruber P; Noiges B; Yatsyk K; Santic R; Mandler M; Staffler G
    J Neuroinflammation; 2015 Aug; 12():150. PubMed ID: 26275910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.